Drug Topics Hospital Pharmacists' Report

September 6, 2012

Web Version  |   Unsubscribe  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TOP STORY

Aspirin may benefit prostate cancer patients

Anticoagulant therapy, particularly the use of aspirin, may reduce the risk of prostate cancer-specific mortality in men treated with radical prostatectomy or radiotherapy for prostate cancer, according to a study published online August 27 in the Journal of Clinical Oncology.
» More

Continuing Education

Enhancing immunization rates

As advocates of public health through immunization, pharmacists can build public awareness, identify patient needs, and provide vaccination services.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

Intravenous aspirin plus alteplase effect on stroke

Early administration of intravenous aspirin, in addition to alteplase, does not improve functional outcome at 3 months for patients with acute ischemic stroke, but increases the risk of symptomatic intracranial hemorrhage, according to a study published online August 25 in The Lancet.
» More

Acetaminophen dosages in overweight children

There is considerable discrepancy among caregivers and pharmacists regarding the appropriate dosage of acetaminophen for overweight and obese children, according to a recent study published online August 20 in the European Journal of Hospital Pharmacy Science and Practice.
» More

FDA approves IBS, constipation treatment

FDA approved linaclotide (Linzess, Ironwood Pharmaceuticals and Forest) to treat chronic idiopathic constipation and to treat irritable bowel syndrome with constipation in adults.

» More

Survey

Who do you plan on voting for in the upcoming 2012 presidential election?


1. Barack Obama

2. Mitt Romney

3. I am not sure at this point

4. I don’t plan on voting because I am not excited about any of the candidates

5. Other candidate

 

Respond here and see what your colleagues think too.


 

Subscribe Now!

You must click here to continue receiving the Drug Topics Hospital Pharmacists' Report

Check these out, too

Treatment for late-stage prostate cancer

FDA approves orphan drug for CML

FDA Drug Safety Communication: Sildenafil

Ivacaftor and potential risk for cataracts

Voices

Anticoagulation Update

JP at Large: Natural not always harmless

View from the Zoo: Do the time warp again

Viewpoints: Guest columnists’ commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group